Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-06-22 16:31:58 ET · period of report 2026-06-18 · accession 0001636178-26-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-22 16:31 | 2026-06-18 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +10.0K | 28.9K | +53% | +$1.46M |
| DMT | 2026-06-22 16:31 | 2026-06-18 | UTHR | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $540.15 | -10.0K | 18.9K | -35% | -$5.40M |
| DT | 2026-06-22 16:31 | 2026-06-18 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $0.00 | -10.0K | 8,750 | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | M | A | 10,000 | $146.03 | 28,876 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |
| 2 | Common | Common Stock | 2026-06-18 | S | D | 400 | $533.59 | 28,476 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $533.25 to $533.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-06-18 | S | D | 160 | $534.48 | 28,316 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $534.39 to $534.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-06-18 | S | D | 210 | $536.27 | 28,106 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $535.73 to $536.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-06-18 | S | D | 600 | $537.24 | 27,506 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $536.76 to $537.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-06-18 | S | D | 1,440 | $538.31 | 26,066 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $537.78 to $538.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-06-18 | S | D | 2,035 | $539.42 | 24,031 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $538.78 to $539.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-06-18 | S | D | 2,978 | $540.22 | 21,053 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $539.78 to $540.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-06-18 | S | D | 865 | $541.06 | 20,188 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F9) This transaction was executed in multiple trades at prices ranging from $540.78 to $541.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-06-18 | S | D | 192 | $541.88 | 19,996 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F10) This transaction was executed in multiple trades at prices ranging from $541.82 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2026-06-18 | S | D | 40 | $543.53 | 19,956 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F11) This transaction was executed in multiple trades at prices ranging from $543.37 to $543.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 12 | Common | Common Stock | 2026-06-18 | S | D | 40 | $545.19 | 19,916 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |
| 13 | Common | Common Stock | 2026-06-18 | S | D | 265 | $547.37 | 19,651 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F12) This transaction was executed in multiple trades at prices ranging from $546.69 to $547.545. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 14 | Common | Common Stock | 2026-06-18 | S | D | 115 | $547.81 | 19,536 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F13) This transaction was executed in multiple trades at prices ranging from $547.69 to $548.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 15 | Common | Common Stock | 2026-06-18 | S | D | 660 | $548.90 | 18,876 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F14) This transaction was executed in multiple trades at prices ranging from $548.69 to $549.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 16 | Derivative | Stock Option | 2026-06-18 | M | D | 10,000 | $0.00 | 8,750 | D | $146.03 · 2020-03-15 to 2027-03-15 | 10,000 Common Stock | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |